Dr Shun Luo, chairman, founder and CEO of Thousand Oaks Biopharmaceuticals, shares the company’s vision to deliver more accessible and affordable biologics to patients globally by lowering the cost of goods manufactured (COGM) per gram of recombinant protein; the paradigm-shifting technology and processes Thousand Oaks Biopharmaceuticals is innovating as an integrated chemistry, manufacturing and controls (CMC) bio-manufacturer; the dry powder cell culture media facility they are building; and the strength and extensive global experience of his leadership team at Thousand Oaks Biopharmaceuticals.
Cell culture technology is the core for bio-manufacturing, not only recombinant proteins but any biologicals, including vaccines as well as gene and cell therapies!
